2009-11-30 07:40:34 - Global pharma market is projected to grow at a CAGR of around 6% during 2010-2012, with developing markets presenting maximum growth opportunities.

The pharma market worldwide has witnessed a slow growth in past few years due to patent expiries of several blockbuster drugs, increasing use of generic drugs and increasing cost containment measures taken by the government. Despite this slowdown, there are several emerging opportunities in developing countries like India, China, Brazil, and Russia, which will drive the future growth of the pharma market. According to our new research study “Global Pharmaceutical Market Forecast to 2012”, it is anticipated that the global pharma market will grow at a CAGR of around 6% during 2010-2012.

We have done a detailed analysis of several regional level markets in order to identify the key emerging trends across these markets. We have found that use of low

cost generic drugs has increased quite significantly due to recessionary effects, and this trend will continue in next few years also. Moreover, outsourcing of manufacturing facilities to emerging countries is also expected to show a robust growth due to low cost factors.

Our research provides comprehensive information on several key pharma markets along with the information of their market size and other important statistics. We have identified that the countries like India, China, Russia, Indonesia and Brazil will provide ample opportunities to investors and will register the maximum growth. However the overall pharma market will continue to be dominated by developed markets like the US, Canada, Germany, Japan and other European countries, but they will lose their share to the aforementioned developing markets. Growth in these regions will also be affected by the after impacts of economic recession as public and private spending will decrease in the next few years.

“Global Pharmaceutical Market Forecast to 2012” also provides brief business profile of the key competitors existing in the market. This will give our client an additional edge over other competitors in the market. Overall, our research study provides valuable information to clients looking to venture into these markets and helps them to devise strategies while heading into an investment/partnership in these markets.

For FREE SAMPLE of this report visit: www.rncos.com/Report/IM149.htm

Check DISCOUNTED REPORTS on: www.rncos.com

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.